Quick Answer
Arcadia Biosciences, Inc. reported Shares Outstanding of 1.37 million shares for fiscal year 2025.
Arcadia Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.37M | +0.6% |
| 2024 | 1.36M | +6.2% |
| 2023 | 1.29M | +108.6% |
| 2022 | 616,079 | +11.1% |
| 2021 | 554,609 | -95.9% |
| 2020 | 13.45M | +55.6% |
| 2019 | 8.65M | +81.1% |
| 2018 | 4.77M | +123.7% |
| 2017 | 2.13M | -4.1% |
| 2016 | 2.22M | -95.0% |
| 2015 | 44.18M | +2030.4% |
| 2014 | 2.07M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.37M | +0.2% | +0.0% |
| June 30, 2025 | 1.37M | +0.3% | +0.0% |
| March 31, 2025 | 1.37M | +0.3% | +0.2% |
| December 31, 2024 | 1.36M | +6.2% | +0.0% |
| September 30, 2024 | 1.36M | +22.9% | +0.2% |
| June 30, 2024 | 1.36M | +23.0% | +0.0% |
| March 31, 2024 | 1.36M | +58.9% | +6.0% |
| December 31, 2023 | 1.29M | +108.6% | +15.8% |
- Arcadia Biosciences, Inc. showed an increase of +0.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2025 period, Arcadia Biosciences, Inc.’s shares outstanding has declined by 33.8% (from 2.07 million shares to 1.37 million shares).
- The most recent figure is from Arcadia Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: